GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Covalon Technologies COV.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

4.43

+2.78%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Covalon Technologies — daily TSXV:COV Delayed
Market value
C$122.4m
Last close × shares
Volume
18.2k
Shares, 9 Nov 2026
Price to earnings
57.2

About Covalon Technologies

Its shares trade on TSX Venture under the ticker COV.V. It has been listed since 3 September 2004. In the fiscal year to 30 September 2025, it reported revenue of C$32.8m and net income of C$2.1m. At that date it held total assets of C$36.1m and shareholders' equity of C$30.7m.

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. The company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. The company provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.

Figures and description from our data supplier, not checked against the company's own report.

More about Covalon Technologies →

Latest on Covalon Technologies

Our reporting

We have not reported on Covalon Technologies yet.

Next results

10 Dec 2026

Due on 10 Dec 2026. Analysts expect earnings of 0.04 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Covalon Technologies's ticker?

Covalon Technologies trades as COV.V on TSX Venture, under ISIN CA22282D3022.

What was Covalon Technologies's last closing price?

4.43 on 9 Nov 2026. The figure is in CAD and is never converted.

When does Covalon Technologies next report results?

Results are expected on 10 Dec 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.